Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectGenetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.
Mobile Apps for DNA Sequencing: Global Markets
The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.
Single-cell Omics: Emerging Technologies and Markets
The global single-cell omics market is expected to grow from $555.3 million in 2017 to nearly $1.6 billion in 2022, at a compound annual growth rate (CAGR) of 23.5% from 2017 to 2022.
Global Markets for Enzyme Inhibitors
The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.
Botanical and Plant-derived Drugs: Global Markets
The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.
Human Microbiome-based Drugs and Diagnostics: Global Markets
The global market for human microbiome-based drugs and diagnostics should reach a market size of nearly $9.9 billion by 2024.
Separation Systems for Commercial Biotechnology
The global market for bioseparation reached $18.4 billion in 2015. This market is expected to increase from $19.0 billion in 2016 to nearly $24.0 billion in 2021 at a compound annual growth rate (CAGR) of 4.7% for 2016-2021.
Global Markets for Protein Labeling
The global protein-labeling market reached $2.2 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 14.1% from 2016 to 2021.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
The global market for biochip products reached nearly $3.9 billion in 2014. This market is projected to grow from $4.7 billion in 2015 to $18.4 billion in 2020, representing a compound annual growth rate (CAGR) of 31.6% between 2015 and 2020.
Cell Expansion Technologies and Global Markets
The global cell expansion market generated revenue of roughly $8.5 billion in 2014, and is expected to reach revenues of $9.7 billion in 2015 and $22.0 billion by 2020, with a compound annual growth rate (CAGR) of 17.8% from 2015 to 2020.
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Ma...
The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to about $610.3 million in 2015 and about $5.4 billion in 2019, with a compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
Global Markets for Nanoparticle Size Analysis Instrumentation in ...
The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Glo...
The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on blood factors, vaccines and peptide antibiotics. The report includes sales forecasts for year 2013 and 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on cytokines and monoclonal antibodies. The report includes sales forecasts for year 2013 and 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on peptide hormones and therapeutic enzymes. The report includes sales forecasts for year 2013 and 2018.
Environmental Markets for Biotechnology
U.S. sales of environmental biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.
Immunoassays: Technologies and Global Markets -- Focus on Infecti...
This study focuses on immunoassays for infectious disease and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets.
Immunoassays: Technologies and Global Markets -- Focus on Immunoa...
This study focuses on immunoassays for drug screening and is a sub report of BIO033B: Immunoassays: Technologies and Global Markets
Choose your License
Biosimilars: Global Markets
This report provides a complete review and analysis of the current biosimilars market and industry growth drivers and challenges.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The report provides an overview of the industry structure and its competitive landscape of the market for liquid biopsy research tools, services and diagnostics. It covers market projections through 2029.
Cell-Based Assays: Technologies and Global Markets
This report provides an in-depth analysis of the global cell-based assays technologies market, segmented by product type, application, and end user. The applications include drug discovery for validating drug targets, lead profiling assays, absorption, distribution, metabolism, and excretion (ADME) toxicity assays, and basic research.
Global Markets for Enzymes in Industrial Applications
This report provides an overview of the current and future characteristics of the global market for enzymes for industrial applications. This study measures and forecasts the industrial enzyme market based on different types of enzymes.
Therapeutics for Women's Health: Technologies and Global Markets
This study focuses on health issues associated specifically with women. This study provides an overview of products in this market and detailed analyses of markets and competitive environments.
Current Research & Development Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy
This report provides a comprehensive analysis of products, technologies and applications of CAR-T cells therapy.
Global Markets for Media, Sera and Reagents in Biotechnology
This report is an updated version of an earlier BCC study published in 2021. The objective of this report is to create an overview of the current and future scope and developments in the global market for media, sera and reagents used in the biotechnology industry.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets
This report offers an in-depth analysis of the GPCR targeting technologies and global market, including market forecasts and sales projections for 2029. It examines the market by segmenting it into various product categories.
Organ-on-a-Chip: Global Markets
The report provides an overview of the global organ-on-a-chip market and analyzes market trends.
Single-cell Omics: Emerging Technologies and Markets
This report provides a complete review and analysis of the current single-cell genomics and proteomics market and industry growth drivers and challenges. The report comprehensively covers the key competitor activities in the single-cell genomics and proteomics market.